Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 538

1.

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey.

Lane DA, Meyerhoff J, Rohner U, Lip GYH.

TH Open. 2018 Jul 5;2(3):e233-e241. doi: 10.1055/s-0038-1666803. eCollection 2018 Jul.

2.

Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial.

Montalescot G, Brotons C, Cosyns B, Crijns HJ, D'Angelo A, Drouet L, Eberli F, Lane DA, Besse B, Chan A, Vicaut E, Darius H; AEGEAN Study Investigators.

Am J Cardiovasc Drugs. 2019 Jun 26. doi: 10.1007/s40256-019-00356-2. [Epub ahead of print]

PMID:
31243691
3.

Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study.

Højen AA, Søgaard M, Melgaard L, Lane DA, Sørensen EE, Goldhaber SZ, Larsen TB.

BMJ Open. 2019 May 14;9(5):e026159. doi: 10.1136/bmjopen-2018-026159.

4.

Anticoagulation for Atrial Fibrillation in Older Adults-Using Big Data for Big Questions.

Quinn TJ, Lane DA.

Thromb Haemost. 2019 Jun;119(6):855-857. doi: 10.1055/s-0039-1688482. Epub 2019 Apr 30. No abstract available.

PMID:
31041792
5.

Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines.

Proietti M, Lane DA, Boriani G, Lip GYH.

Can J Cardiol. 2019 May;35(5):619-633. doi: 10.1016/j.cjca.2019.02.009. Epub 2019 Feb 21. Review.

PMID:
31030864
6.

Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial.

Guo Y, Lane DA, Wang L, Chen Y, Lip GYH; mAF-App II Trial investigators.

Int J Clin Pract. 2019 Jul;73(7):e13352. doi: 10.1111/ijcp.13352. Epub 2019 Jun 3.

PMID:
31002434
7.

The Liverpool Centre for Cardiovascular Science.

Lip GYH, Lane DA.

Eur Heart J. 2019 Mar 21;40(12):957-958. doi: 10.1093/eurheartj/ehz107. No abstract available.

PMID:
30896770
8.

Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).

Arnar DO, Mairesse GH, Boriani G, Calkins H, Chin A, Coats A, Deharo JC, Svendsen JH, Heidbüchel H, Isa R, Kalman JM, Lane DA, Louw R, Lip GYH, Maury P, Potpara T, Sacher F, Sanders P, Varma N, Fauchier L; ESC Scientific Document Group ; EHRA Scientific Documents Committee .

Europace. 2019 Mar 18. pii: euz046. doi: 10.1093/europace/euz046. [Epub ahead of print]

PMID:
30882141
9.

Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.

Lane DA, Dagres N, Dan GA, García Seara J, Iliodromitis K, Lenarczyk R, Lip GYH, Mansourati J, Marín F, Scherr D, Potpara TS.

Europace. 2019 Mar 14. pii: euz033. doi: 10.1093/europace/euz033. [Epub ahead of print]

PMID:
30874724
10.

Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.

Diener HC, Hart RG, Koudstaal PJ, Lane DA, Lip GYH.

J Am Coll Cardiol. 2019 Feb 12;73(5):612-619. doi: 10.1016/j.jacc.2018.10.077. Review.

PMID:
30732716
11.

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review.

Pritchett RV, Bem D, Turner GM, Thomas GN, Clarke JL, Fellows R, Lane DA, Jolly K.

Thromb Haemost. 2019 Feb;119(2):294-307. doi: 10.1055/s-0038-1676835. Epub 2019 Jan 22.

PMID:
30669165
12.

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Newnham M, South K, Bleda M, Auger WR, Barberà JA, Bogaard H, Bunclark K, Cannon JE, Delcroix M, Hadinnapola C, Howard LS, Jenkins D, Mayer E, Ng C, Rhodes CJ, Screaton N, Sheares K, Simpson MA, Southwood M, Su L, Taboada D, Traylor M, Trembath RC, Villar SS, Wilkins MR, Wharton J, Gräf S, Pepke-Zaba J, Laffan M, Lane DA, Morrell NW, Toshner M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1801805. doi: 10.1183/13993003.01805-2018. Print 2019 Mar.

13.

Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Reavell J, Hopkinson M, Clarkesmith D, Lane DA.

Psychosom Med. 2018 Oct;80(8):742-753. doi: 10.1097/PSY.0000000000000626.

PMID:
30281027
14.

Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway.

Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH.

Am J Med. 2018 Nov;131(11):1359-1366.e6. doi: 10.1016/j.amjmed.2018.06.012. Epub 2018 Aug 26.

PMID:
30153428
15.

Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.

South K, Denorme F, Salles-Crawley II, De Meyer SF, Lane DA.

J Thromb Haemost. 2018 Nov;16(11):2289-2299. doi: 10.1111/jth.14275. Epub 2018 Oct 24.

16.

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.

Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.

Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.

PMID:
30144419
17.

Qualitative exploration of the effect of a television soap opera storyline on women with experience of postpartum psychosis.

Roberts L, Berrisford G, Heron J, Jones L, Jones I, Dolman C, Lane DA.

BJPsych Open. 2018 Mar 19;4(2):75-82. doi: 10.1192/bjo.2018.9. eCollection 2018 Mar.

18.

Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?

Proietti M, Lane DA.

Thromb Haemost. 2018 Jul;118(7):1123-1126. doi: 10.1055/s-0038-1661370. Epub 2018 Jul 2. No abstract available.

PMID:
29966164
19.

Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes.

Garcia-Bonilla L, Brea D, Benakis C, Lane DA, Murphy M, Moore J, Racchumi G, Jiang X, Iadecola C, Anrather J.

J Neurosci. 2018 Jul 25;38(30):6722-6736. doi: 10.1523/JNEUROSCI.0324-18.2018. Epub 2018 Jun 26.

20.

Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence.

Székely O, Lane DA, Lip GYH.

Eur Heart J. 2018 Jul 1;39(25):2365-2367. doi: 10.1093/eurheartj/ehy308. No abstract available.

PMID:
29878099
21.

Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries.

Proietti M, Laroche C, Nieuwlaat R, Crijns HJGM, Maggioni AP, Lane DA, Boriani G, Lip GYH; EORP-AF General Pilot Registry; Euro Heart Survey on AF Investigators.

Eur J Intern Med. 2018 Sep;55:28-34. doi: 10.1016/j.ejim.2018.05.016. Epub 2018 May 16.

PMID:
29778588
22.

Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.

Lane DA, Meyerhoff J, Rohner U, Lip GYH.

Clin Cardiol. 2018 Jun;41(6):855-861. doi: 10.1002/clc.22971. Epub 2018 Jun 12.

23.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Bautista-Vargas WF, Chiang CE, Cuesta A, Dan GA, Frankel DS, Guo Y, Hatala R, Lee YS, Murakawa Y, Pellegrini CN, Pinho C, Milan DJ, Morin DP, Nadalin E, Ntaios G, Prabhu MA, Proietti M, Rivard L, Valentino M, Shantsila A.

J Arrhythm. 2018 Mar 23;34(2):99-123. doi: 10.1002/joa3.12050. eCollection 2018 Apr. No abstract available.

24.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK.

Heart Rhythm. 2018 Jun;15(6):e37-e60. doi: 10.1016/j.hrthm.2018.03.005. Epub 2018 Mar 18. No abstract available.

PMID:
29563045
25.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK; ESC Scientific Document Group.

Europace. 2018 Sep 1;20(9):1399-1421. doi: 10.1093/europace/euy046. No abstract available.

PMID:
29562326
26.

Cognitive Behavioral Therapy for Depression, Anxiety, and Stress in Caregivers of Dementia Patients: A Systematic Review and Meta-Analysis.

Hopkinson MD, Reavell J, Lane DA, Mallikarjun P.

Gerontologist. 2019 Jul 16;59(4):e343-e362. doi: 10.1093/geront/gnx217.

PMID:
29529290
27.

Epidemiology of atrial fibrillation.

Zulkifly H, Lip GYH, Lane DA.

Int J Clin Pract. 2018 Mar;72(3):e13070. doi: 10.1111/ijcp.13070. Epub 2018 Mar 1.

PMID:
29493854
28.

Biphasic activation of complement and fibrinolysis during the human nasal allergic response.

Thwaites RS, Gunawardana NC, Broich V, Mann EH, Ahnström J, Campbell GA, Lindsley S, Singh N, Tunstall T, Lane DA, Openshaw PJ, Hawrylowicz CM, Hansel TT.

J Allergy Clin Immunol. 2018 May;141(5):1892-1895.e6. doi: 10.1016/j.jaci.2018.01.022. Epub 2018 Feb 7. No abstract available.

29.

A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.

South K, Freitas MO, Lane DA.

J Biol Chem. 2018 Jan 26;293(4):1149-1150. doi: 10.1074/jbc.AAC117.001638. Epub 2018 Jan 26. No abstract available.

30.

Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.

Lip GYH, Lane DA, Potpara TS.

Eur Heart J. 2018 Apr 21;39(16):1404-1406. doi: 10.1093/eurheartj/ehx807. No abstract available.

PMID:
29325061
31.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.

Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A, Goette A, Guasch E, Haase D, Hatem S, Haeusler KG, Heidbuchel H, Hendriks J, Hunter C, Kääb S, Kespohl S, Landmesser U, Lane DA, Lewalter T, Mont L, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Pison L, Potpara T, Ravens U, Richard-Lordereau I, Rienstra M, Savelieva I, Schnabel R, Sinner MF, Sommer P, Themistoclakis S, Van Gelder IC, Vardas PE, Verma A, Wakili R, Weber E, Werring D, Willems S, Ziegler A, Hindricks G, Kirchhof P.

Europace. 2018 Mar 1;20(3):395-407. doi: 10.1093/europace/eux318.

32.

Individual depressive symptoms and all-cause mortality In 6673 patients with myocardial infarction: Heterogeneity across age and sex subgroups.

de Miranda Azevedo R, Roest AM, Carney RM, Freedland KE, Lane DA, Parakh K, de Jonge P, Denollet J.

J Affect Disord. 2018 Mar 1;228:178-185. doi: 10.1016/j.jad.2017.11.025. Epub 2017 Nov 16.

PMID:
29253684
34.

A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Lynch CJ, Cawte AD, Millar CM, Rueda D, Lane DA.

PLoS One. 2017 Nov 29;12(11):e0188405. doi: 10.1371/journal.pone.0188405. eCollection 2017.

35.

Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review.

Zulkifly H, Lip GYH, Lane DA.

Heart Rhythm. 2018 Apr;15(4):615-623. doi: 10.1016/j.hrthm.2017.11.026. Epub 2017 Nov 24. Review.

PMID:
29180122
36.

ADAMTS-13 and von Willebrand factor: a dynamic duo.

South K, Lane DA.

J Thromb Haemost. 2018 Jan;16(1):6-18. doi: 10.1111/jth.13898. Epub 2017 Dec 2. Review.

38.

Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation.

Lip GYH, Lane DA, Sarwar S.

Eur Heart J. 2017 Oct 21;38(40):2980-2982. doi: 10.1093/eurheartj/ehx554. No abstract available.

PMID:
29088442
39.

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.

Proietti M, Hijazi Z, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Lane DA, Oldgren J, Roldan V, Yusuf S, Wallentin L; RE-LY Investigators.

J Intern Med. 2018 Mar;283(3):282-292. doi: 10.1111/joim.12702. Epub 2017 Nov 7.

PMID:
29044861
40.

Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial.

Guo Y, Chen Y, Lane DA, Liu L, Wang Y, Lip GYH.

Am J Med. 2017 Dec;130(12):1388-1396.e6. doi: 10.1016/j.amjmed.2017.07.003. Epub 2017 Aug 26.

41.

Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism.

Zulkifly H, Lip GYH, Lane DA.

Am J Cardiol. 2017 Oct 1;120(7):1139-1145. doi: 10.1016/j.amjcard.2017.06.058. Epub 2017 Jul 14. Review.

PMID:
28800833
42.

Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry.

Mazurek M, Shantsila E, Lane DA, Wolff A, Proietti M, Lip GYH.

Mayo Clin Proc. 2017 Aug;92(8):1203-1213. doi: 10.1016/j.mayocp.2017.05.023.

PMID:
28778255
43.

Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis.

Jeyanantham K, Kotecha D, Thanki D, Dekker R, Lane DA.

Heart Fail Rev. 2017 Nov;22(6):731-741. doi: 10.1007/s10741-017-9640-5. Review.

44.

Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.

Mazurek M, Shantsila E, Lane DA, Wolff A, Proietti M, Lip GYH.

Stroke. 2017 Aug;48(8):2198-2205. doi: 10.1161/STROKEAHA.116.016146. Epub 2017 Jul 5.

PMID:
28679859
45.

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care.

Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D.

J Am Heart Assoc. 2017 Apr 28;6(5). pii: e005155. doi: 10.1161/JAHA.116.005155.

46.

Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.

Proietti M, Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Sinagra G, Dan GA, Maggioni AP, Tavazzi L, Lane DA, Lip GYH; EORP-AF General Pilot Registry Investigators.

Europace. 2017 Apr 1;19(4):535-543. doi: 10.1093/europace/euw150.

PMID:
28431068
47.

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.

Santamaria S, Reglińska-Matveyev N, Gierula M, Camire RM, Crawley JTB, Lane DA, Ahnström J.

J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.

48.

Third-harmonic-generation of a diode laser for quantum control of beryllium ions.

Carollo RA, Lane DA, Kleiner EK, Kyaw PA, Teng CC, Ou CY, Qiao S, Hanneke D.

Opt Express. 2017 Apr 3;25(7):7220-7229. doi: 10.1364/OE.25.007220.

PMID:
28380847
49.

Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Clarkesmith DE, Pattison HM, Khaing PH, Lane DA.

Cochrane Database Syst Rev. 2017 Apr 5;4:CD008600. doi: 10.1002/14651858.CD008600.pub3. Review.

50.

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries.

Ogawa H, Senoo K, An Y, Shantsila A, Shantsila E, Lane DA, Wolff A, Akao M, Lip GYH.

EBioMedicine. 2017 Apr;18:199-203. doi: 10.1016/j.ebiom.2017.03.022. Epub 2017 Mar 16.

Supplemental Content

Support Center